Page last updated: 2024-12-11

clinoptilolite

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

clinoptilolite: clinoptilolite was SY to zeolite (NM); use zeolites (NM) to search through 1993; RN is for cpd with unknown MF [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6336554
MeSH IDM0221376

Synonyms (5)

Synonym
clinoptilolite
12173-10-3
JYIBXUUINYLWLR-UHFFFAOYSA-N
DTXSID501019924 ,
clinoptilolite ((k0-1na0-1ca0-0.5)6(al6si30o72).20h2o)

Research Excerpts

Overview

Clinoptilolite is an aluminium silicate of natural origin. The microporous structure and the net negative charge of its crystal lattice allows for adsorption of ions, toxins, inflammatory mediators, and some microorganisms.

ExcerptReferenceRelevance
"Clinoptilolite is a natural mineral with exceptional physical characteristics resulting from its special crystal structure, mainstreamed into a large zeolite group called heulandites. "( Synthesis and Modification of Clinoptilolite.
Ambrozova, P; Kynicky, J; Nguyen, VD; Urubek, T, 2017
)
2.19
"Clinoptilolite is an aluminium silicate of natural origin; the microporous structure and the net negative charge of its crystal lattice allows for adsorption of ions, toxins, inflammatory mediators, and some microorganisms. "( Clinoptilolite in Dextran Sulphate Sodium-Induced Murine Colitis: Efficacy and Safety of a Microparticulate Preparation.
Abuja, PM; Berger, T; Fiebich, BL; Freissmuth, M; Kashofer, K; Kenner, L; Meisslitzer-Ruppitsch, C; Muñoz, E; Nagl, D; Nizet, S; Scheichl, L; Tangermann, S; Tschegg, C; Zatloukal, K, 2017
)
3.34
"Clinoptilolite is a natural zeolite which due to high surface area/volume ratio has found many applications in industries and medicine. "( Feasibility of clinoptilolite application as a microporous carrier for pH-controlled oral delivery of aspirin.
Parsa, MJ; Sharifi, AM; Shetab-Boushehri, SV; Tondar, M; Yousefpour, Y, 2014
)
2.2
"Clinoptilolite is a natural zeolite crystal. "( Effects of clinoptilolite treatment on oxidative stress after partial hepatectomy in rats.
Aydin, S; Aytac, E; Ozbay, G; Pekmezci, S; Saribeyoglu, K; Saygili, S; Seymen, HO; Uzun, H, 2011
)
2.2
"Clinoptilolite was found to be a suitable material for PRBs against the contaminated groundwater with ammonium and/or heavy metals."( Lab scale experiments for permeable reactive barriers against contaminated groundwater with ammonium and heavy metals using clinoptilolite (01-29B).
Lee, CY; Lee, JW; Lee, SH; Park, JB, 2002
)
1.24
"Clinoptilolite is a zeolite mineral with high cation exchange capacity used in zeoponic substrates that have been proposed as a solid medium for growing plants or as a fertilizer material. "( Nitrification in a zeoponic substrate.
Gruener, JE; McGilloway, RL; Ming, DW; Weaver, RW, 2003
)
1.76
"Clinoptilolite is a kind of natural zeolite and it was used due to its good pozzolanic characteristic and its abundant reserves in Turkey."( Industrial sludge solidification by using clinoptilolite.
Balkan, M; Kocasoy, G, 2004
)
1.31
"Clinoptilolite is a nontoxic natural zeolite with properties of an ion-exchanger and adsorbent. "( A clinoptilolite effect on cell media and the consequent effects on tumor cells in vitro.
Bosnjak, B; Dikic, I; Gall-Troselj, K; Katic, M; Pavelic, K, 2006
)
2.5

Treatment

Clinoptilolite treatment of mice and dogs suffering from a variety of tumor types led to improvement in the overall health status, prolongation of life-span, and decrease in tumors size.

ExcerptReferenceRelevance
"Raw clinoptilolite (Raw-CL) was treated with Fe(NO3)3 in ethanol to obtain its iron-grafted form (Fe-CL)."( Enhancement of the anionic dye adsorption capacity of clinoptilolite by Fe(3+)-grafting.
Akgül, M, 2014
)
1.13
"Clinoptilolite treatment of mice and dogs suffering from a variety of tumor types led to improvement in the overall health status, prolongation of life-span, and decrease in tumors size."( Natural zeolite clinoptilolite: new adjuvant in anticancer therapy.
Bedrica, L; Bosnar, MH; Colić, M; Dikić, I; Hadzija, M; Jurin, M; Kapitanović, S; Katić, M; Kralj, M; Krizanac, S; Pavelić, J; Pavelić, K; Poljak-Blazi, M; Stojković, R; Subotić, B, 2001
)
1.38
"In clinoptilolite-rich-zeolite-treated animals only a slight decrease in protozoan numbers occurred during the first hours after the intoxication."( Influence of intoxication with organophosphates on rumen bacteria and rumen protozoa and protective effect of clinoptilolite-rich zeolite on bacterial and protozoan concentration in rumen.
Kovác, G; Mojzis, J; Nistiar, F; Rácz, O; Seidel, H, 2000
)
1.03

Toxicity

ExcerptReferenceRelevance
"The aim of our study was to determine the efficacy of three different adsorbents, inorganic (modified zeolite), organic (esterified glucomannans) and mixed (inorganic and organic components, with the addition of enzymes), in protecting broilers from the toxic effects of ochratoxin A in feed."( Comparative investigation of the efficacy of three different adsorbents against OTA-induced toxicity in broiler chickens.
Jovanovic, M; Milićević, D; Nedeljković-Trailović, J; Resanović, R; Trailović, S; Vasiljevic, M, 2015
)
0.42
"Our observations confirm that a microparticulate preparation of clinoptilolite is safe and effective in a murine model of inflammatory bowel disease and supports the hypothesis that the adsorptive capacity of clinoptilolite is of potential therapeutic relevance."( Clinoptilolite in Dextran Sulphate Sodium-Induced Murine Colitis: Efficacy and Safety of a Microparticulate Preparation.
Abuja, PM; Berger, T; Fiebich, BL; Freissmuth, M; Kashofer, K; Kenner, L; Meisslitzer-Ruppitsch, C; Muñoz, E; Nagl, D; Nizet, S; Scheichl, L; Tangermann, S; Tschegg, C; Zatloukal, K, 2017
)
2.14

Bioavailability

ExcerptReferenceRelevance
" Our objectives in this study were twofold: (1) to utilize the pregnant rat as an in vivo model to compare the potential of HSCAS and clinoptilolite to prevent the developmental toxicity of aflatoxin B1 (AfB1), and (2) to determine the effect of these two sorbents on the metabolism and bioavailability of AfB1."( Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents: potential for hidden risks.
Abdel-Wahhab, MA; Edwards, JF; Mayura, K; McKenzie, KS; Naguib, K; Phillips, TD; Sarr, AB, 1998
)
0.5
" The results indicated that ZnCP reached a higher bioavailability as compared with ZnSO4 as evidenced by enhanced tissue Zn accumulation and Zn transporter genes expression."( Zinc-bearing zeolite clinoptilolite improves tissue zinc accumulation in laying hens by enhancing zinc transporter gene mRNA abundance.
Chen, Y; Li, L; Li, P; Wen, C; Zhou, Y; Zhuang, S, 2015
)
0.74
"Solid additives were used as a microwave absorber to improve the low microwave absorption rate of switchgrass going through pyrolysis, and as a catalyst to improve the bio-oil and biochar characteristics."( Microwave-assisted catalytic pyrolysis of switchgrass for improving bio-oil and biochar properties.
Bi, X; Ellis, N; Kim, CS; Mohamed, BA, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" Animals receiving AfB1 were dosed orally (between days 6 and 13) with AfB1 (2 mg/kg body wt) either alone or concomitantly with a similar quantity of the respective sorbent."( Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents: potential for hidden risks.
Abdel-Wahhab, MA; Edwards, JF; Mayura, K; McKenzie, KS; Naguib, K; Phillips, TD; Sarr, AB, 1998
)
0.3
" The adsorption of NH4(+) was investigated as a function of the solution pH, dosage of adsorbent, initial ammonium concentration and temperature."( Investigation on natural and pretreated Bulgarian clinoptilolite for ammonium ions removal from aqueous solutions.
Vassileva, P; Voikova, D, 2009
)
0.61
"65% at pH 6, adsorbent dosage 11."( The design and implementation of adsorptive removal of Cu(II) from leachate using ANFIS.
Ozgonenel, O; Turan, NG, 2013
)
0.39
" Analysis of variance (ANOVA) for response surface quadratic model revealed that the model was significant with dosage and agitation speed connoting the main significant process factors for the optimization."( Optimization of Manganese Reduction in Biotreated POME onto 3A Molecular Sieve and Clinoptilolite Zeolites.
Amosa, MK; Jami, MS; Rosli, NS, 2016
)
0.66
" The BCNU@HCLI system was chosen to develop gel and cream semisolid dosage forms."( Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.
Ghiciuc, CM; Grigorovici, A; Ignat, M; Lupusoru, CE; Ochiuz, L; Solcan, C; Stoleriu, I; Strat, AL; Vasile, A, 2017
)
0.67
" However, the continuous dosing of soluble ES would rise operation cost and cause contamination inevitably."( Simultaneous removal of refractory organic pollutants and nitrogen using electron shuttle suspended biofilm carriers in an integrated hydrolysis/acidification-anoxic/aerobic process.
Liang, K; Liu, T; Quan, X, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (355)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (2.54)18.2507
2000's128 (36.06)29.6817
2010's156 (43.94)24.3611
2020's62 (17.46)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.41 (24.57)
Research Supply Index5.98 (2.92)
Research Growth Index5.44 (4.65)
Search Engine Demand Index132.47 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (43.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials23 (6.22%)5.53%
Reviews3 (0.81%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.27%)0.25%
Other343 (92.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]